Evidence map›Paper›PMID 39984883›Full record

ArticleBMC cancer2025

Incidence trends of early-onset breast cancer by lifestyle risk factors.

Jasmiina Rantala, Karri Seppä, Johan Eriksson, Sirpa Heinävaara, Tommi Härkänen, Pekka Jousilahti, Paul Knekt, Satu Männistö, Ossi Rahkonen, Nea Malila and 6 more

Abstract read
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Breast cancer diagnosis as a window of opportunity for smoking cessation: analysis of changes in smoking behaviour in 736 smoking breast cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Early- versus late-onset mortality trends in breast and female genital cancers in Spain, 1999-2024.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jasmiina RantalaFinnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland. jasmiina.rantala@cancer.fi.ORCID https://orcid.org/0000-0001-5821-2944
Karri SeppäFinnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.
Johan ErikssonDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Sirpa HeinävaaraFinnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.
Tommi HärkänenDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Pekka JousilahtiDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Paul KnektDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Satu MännistöDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Ossi RahkonenDepartment of Public Health, University of Helsinki, Helsinki, Finland.
Nea MalilaFinnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.
Eetu MäkinenFinnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.
Heidi RyynänenFinnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.
Maarit LaaksonenDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Sanna HeikkinenFinnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.
Janne PitkäniemiFinnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.
METCA Study Group

Funding

Cancer Institute NSW 2019/CDF1022
6 · The paper itself

Abstract

backgroundThe incidence of early-onset breast cancer (< 50 years) has been increasing over the past decades with the role of modifiable, lifestyle-related risk factors remaining mostly unidentified.

methodsTo investigate the role of key lifestyle factors in the incidence trends of early-onset breast cancer (EOBC), we pooled data from six health studies in Finland in 1972-2015 and combined them with breast cancer data from the Finnish Cancer Registry. The cohort consisted of 56,253 women with 397 EOBCs. The effects of risk factors (hazard ratios) on EOBC and average annual percent change (AAPC) of incidence were estimated using Poisson regression models.

resultsThe highest annual increase in age-standardized incidence was observed among women aged 40-49 who were overweight (AAPC 4.0%, 95% CI 0.5-7.7%), currently smoking (AAPC 3.3%, 95% CI 0.1-6.6%) or moderately physically active (AAPC 2.9%, 95% CI 0.3-5.6%).

conclusionsThe increase in early-onset breast cancer incidence was highest among women aged 40-49 who were overweight, currently smoking, or moderately physically active, while no change by risk factors was found in women under 40 years of age. Our findings suggest a different type of cancer process in young adults and highlight the importance of lifestyle risk factors in the incidence of EOBC.

Indexed as

Breast NeoplasmsLife StyleAdolescentAdultAge of OnsetFemaleFinlandHumansIncidenceMiddle AgedOverweightRisk FactorsSmokingYoung AdultEarly-onset breast cancerIncidence trendsPreventionRisk factors

Identifiers

PMID39984883
PMCPMC11846213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.